For Business Use Only. Does Not Ship to Residential Addresses. For use inside an Analyzer, Sold Separately.

Thermo Kit EtG Rgt DRI CJF

https://www.blockscientific.com/web/image/product.template/97754/image_1920?unique=1400e5e

443.45 443.45 USD 443.45

443.45

    This combination does not exist.

    In Stock

    Product code: T-10016154

    MPN: 10016154

    Manufacturer: Thermo Scientific

    Shipping Weight: 2.00lbs (0.91kg)

    Sales Rep
    Meet your sales rep Lee Doughton, for the West USA region.

    Would you like to schedule a 30-minute consultation with Lee Doughton?

    Yes, Schedule a call

    Thermo Kit EtG Rgt DRI CJF

    Specifications

    • Brand: DRI®
    • Manufacturer: Ortho Clinical Diagnostics
    • Country of Origin: United States
    • Application: Reagent
    • For Use With: For Clinical Chemistry Analyzers
    • Form: Liquid
    • Sample Type: Urine Sample
    • Storage Requirements: Requires Refrigeration
    • Test Name: Ethyl Glucuronide (EtG)
    • Test Type: Drugs of Abuse
    • Volume: 3x18 mL


    Intended Use

    The Thermo ScientificTM DRI Ethyl Glucuronide Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of Ethyl Glucuronide in human urine at cutoffs of 500 ng/mL and 1000 ng/mL.


    Summary and Explanation of the Test

    Ethyl Glucuronide (EtG) is a direct metabolite of ethanol, which is formed by enzymatic conjugation of ethanol with glucuronic acid. Alcohol in urine is normally detected for only a few hours, where as EtG can be detected up to several days even after complete elimination of alcohol from the body. Currently EtG is monitored by GC/MS and LC/MS/MS.

    The DRI® Ethyl Glucuronide Assay is supplied as a liquid ready-to-use homogeneous enzyme immunoassay. The assay uses specifi c antibodies that can detect Ethyl Glucuronide without any significant cross-reactivity to other glucuronide compounds. The assay is based on competition between a drug labeled with glucose-6-phosphate dehydrogenase (G6PDH), and free drug from the urine sample for a fi xed amount of specifi c antibody binding sites. In the absence of free drug from the sample, the specifi c antibody binds the drug labeled with G6PDH and causes a decrease in enzyme activity. This phenomenon creates a direct relationship between the drug concentration in urine and enzyme activity. Active enzyme converts NAD to NADH resulting in an absorbance change that can be measured spectrophotometrically at 340 nm.




    Free, Simple Tactics to Lower Your Cost Per Test

    Get the free guide that shows exactly how to reduce your cost per test using 35 proven tactics, or use the free, fast cost-per-test reduction planner to build a simple, personalized action plan with tactics your lab can implement to reduce wasted budget this year.